Figure 2From: New targets for therapy in breast cancer: Farnesyltransferase inhibitorsDose-related effects of the farnesyltransferase inhibitor tipifranib on the growth of oestrogen receptor-positive MCF-7 breast cancer xenografts. Reproduced with permission from Kelland and coworkers 19.Back to article page